Physician profile
Mark Ayzenberg
NPI 1144563818
$13,462.50
in general payments reported to CMS, 2019-2025
15 companies · $397 in 2025
The $397 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,120 · 2020: $210 · 2021: $53.17 · 2022: $475 · 2023: $208 · 2024: $3,000 · 2025: $397.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,264 · Travel and Lodging: $1,072 · Education: $269.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,263.57 |
| Travel and Lodging | $1,072.23 |
| Education | $268.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $4,948.59 | 2019-2025 | Bone Anchors With Arthroscopic Delivery System, Ultrabutton |
| Arthrex, INC. | $3,509.23 | 2019-2024 | Arthrex |
| Zimmer Biomet Holdings, INC. | $2,869.32 | 2019-2025 | Tapestry, Comprehensive Shoulder System, Gel-One Cross-Linked Hyaluronate |
| Stryker Corporation | $1,267.27 | 2019-2025 | Gamma, T2 Alpha, Tornier Flex |
| Paladin Technology Solutions | $263.13 | 2024-2025 | |
| Linvatec Corporation | $148.88 | 2024 | Biobrace 23mm |
| Fx Shoulder Solutions, INC | $146.74 | 2020-2025 | |
| Extremity Medical | $119.80 | 2019 | |
| Depuy Synthes Sales INC. | $58.64 | 2024-2025 | Truespan Orthocord, Milagro, Monovisc |
| Bioventus LLC | $31.33 | 2025 | Xcell |
| Inari Medical, INC. | $25.97 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Fidia Pharma USA INC. | $24.59 | 2025 | Hymovis |
| Orthofix Medical, INC. | $21.17 | 2024 | Physio-Stim |
| Djo, LLC | $14.10 | 2025 | Donjoy |
| Davol INC. | $13.74 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Ayzenberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.